4//SEC Filing
NEOGENOMICS INC 4
Accession 0001144204-13-066773
$NEOCIK 0001077183operating
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:37 PM ET
Size
11.8 KB
Accession
0001144204-13-066773
Insider Transaction Report
Form 4
GASPARINI ROBERT P
DirectorChief Science Officer
Transactions
- Sale
Common Stock
2013-12-11$3.70/sh−20,000$74,000→ 24,758 total - Sale
Common Stock
2013-12-10$3.70/sh−100$370→ 44,758 total
Holdings
- 100,000
Stock Option (Right to buy)
Exercise: $1.47From: 2007-02-13Exp: 2017-02-13→ Common Stock (0 underlying) - 584,000
Stock Option (Right to buy)
Exercise: $0.80From: 2008-03-12Exp: 2015-03-12→ Common Stock (0 underlying) - 150,000
Stock Option Right to Buy)
Exercise: $0.62From: 2009-12-31Exp: 2016-02-01→ Common Stock (0 underlying) - 425,000
Stock Option (Right to buy)
Exercise: $0.25From: 2005-01-03Exp: 2015-01-03→ Common Stock (0 underlying)
Footnotes (2)
- [F1]On March 12, 2008 Mr. Gasparini was granted an option to purchase 784,000 shares. The first vesting and exercisable date was March 12, 2008. On this date 24,000 options vested and then there was to be 45 additional monthly vesting of 8,000 shares for a total of 384,000 options. Included in this grant were 400,000 non-qualified options with an initial vesting on March 12, 2008. From this grant 200,000 options were cancelled. In terms of the remaining 200,000 non-qualified options, 100,000 options are vested and exercisable.
- [F2]On February 2, 2009 Mr. Gasparini was granted an option to purchase 200,000 shares. These were performance options which vest based on various milestones. To date 50,000 shares are vested and exercisable, 50,000 shares have been cancelled and 100,000 shares are unvested.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001077183
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:37 PM ET
- Size
- 11.8 KB